Study of Gene Polymorphisms Involved in the Metabolism and Action of Vitamin D in Amyotrophic Lateral Sclerosis (SLA_Vit_D)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02893605|
Recruitment Status : Completed
First Posted : September 8, 2016
Last Update Posted : July 19, 2017
|Condition or disease|
|Amyotrophic Lateral Sclerosis|
|Study Type :||Observational|
|Actual Enrollment :||800 participants|
|Official Title:||Study of Gene Polymorphisms Involved in the Metabolism and Action of Vitamin D in Amyotrophic Lateral Sclerosis|
|Study Start Date :||March 2014|
|Actual Primary Completion Date :||May 2017|
|Actual Study Completion Date :||May 2017|
Patients have a sporadic form of Amyotrophic Lateral Sclerosis.
Controls correspond to spouses/partners of patients.
- The polymorphisms occurring on a pre-defined set of genes [ Time Frame: Day 0 (transversal study) ]The genes studied are: CYP2R1, CYP27A1, CYP3A4, CYP2J2, CYP27B1, CYP24A1, VDBP, VDR.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02893605
|CHU de Montpellier - Hôpital Gui de Chauliac|
|Montpellier Cedex 5, France, 34295|
|Principal Investigator:||Kevin Mouzat, MD, PhD||Centre Hospitalier Universitaire de Nîmes|